Institution
University of Auckland
Education•Auckland, New Zealand•
About: University of Auckland is a education organization based out in Auckland, New Zealand. It is known for research contribution in the topics: Population & Context (language use). The organization has 28049 authors who have published 77706 publications receiving 2689366 citations. The organization is also known as: The University of Auckland & Auckland University College.
Topics: Population, Context (language use), Poison control, Health care, Randomized controlled trial
Papers published on a yearly basis
Papers
More filters
••
TL;DR: Assessing the effectiveness of interventions designed to reduce falls by older people in care facilities and hospitals suggested that exercise might reduce falls in people in intermediate level facilities, and increase falls in facilities providing high levels of nursing care.
Abstract: Cochrane review, hvor hensikten var a vurdere effekten av intervensjoner designet for reduksjon av fall blant eldre mennesker i sykehjem og sykehus.
684 citations
••
TL;DR: Two distinct disease phenotypes linked to a single pathogenic mutation can be determined by a common polymorphism.
Abstract: Fatal familial insomnia (FFI) and a subtype of familial Creutzfeldt-Jakob disease (CJD), two clinically and pathologically distinct diseases, are linked to the same mutation at codon 178 (Asn178) of the prion protein gene. The possibility that a second genetic component modified the phenotypic expression of the Asn178 mutation was investigated. FFI and the familial CJD subtype segregated with different genotypes determined by the Asn178 mutation and the methionine-valine polymorphism at codon 129. The Met129, Asn178 allele segregated with FFI in all 15 affected members of five kindreds whereas the Val129, Asn178 allele segregated with the familial CJD subtype in all 15 affected members of six kindreds. Thus, two distinct disease phenotypes linked to a single pathogenic mutation can be determined by a common polymorphism.
677 citations
••
Vardan Khachatryan1, Albert M. Sirunyan1, Armen Tumasyan1, Wolfgang Adam +2134 more•Institutions (142)
TL;DR: The couplings of the Higgs boson are probed for deviations in magnitude from the standard model predictions in multiple ways, including searches for invisible and undetected decays, and no significant deviations are found.
Abstract: Properties of the Higgs boson with mass near 125 GeV are measured in proton-proton collisions with the CMS experiment at the LHC. Comprehensive sets of production and decay measurements are combined. The decay channels include gamma gamma, ZZ, WW, tau tau, bb, and mu mu pairs. The data samples were collected in 2011 and 2012 and correspond to integrated luminosities of up to 5.1 inverse femtobarns at 7 TeV and up to 19.7 inverse femtobarns at 8 TeV. From the high-resolution gamma gamma and ZZ channels, the mass of the Higgs boson is determined to be 125.02 +0.26 -0.27 (stat) +0.14 -0.15 (syst) GeV. For this mass value, the event yields obtained in the different analyses tagging specific decay channels and production mechanisms are consistent with those expected for the standard model Higgs boson. The combined best-fit signal relative to the standard model expectation is 1.00 +/- 0.09 (stat) +0.08 -0.07 (theo) +/- 0.07 (syst) at the measured mass. The couplings of the Higgs boson are probed for deviations in magnitude from the standard model predictions in multiple ways, including searches for invisible and undetected decays. No significant deviations are found.
677 citations
••
TL;DR: Ranibizumab is effective in improving BCVA and is well tolerated in DME, and future clinical trials are required to confirm its long-term efficacy and safety.
Abstract: OBJECTIVE The expression of vascular endothelial growth factor (VEGF) is elevated in diabetic macular edema (DME). Ranibizumab binds to and inhibits multiple VEGF variants. We investigated the safety and efficacy of ranibizumab in DME involving the foveal center. RESEARCH DESIGN AND METHODS This was a 12-month, multicenter, sham-controlled, double-masked study with eyes (age >18 years, type 1 or 2 diabetes, central retinal thickness [CRT] ≥300 μm, and best corrected visual acuity [BCVA] of 73–39 ETDRS letters [Early Treatment Diabetic Retinopathy Study]) randomly assigned to intravitreal ranibizumab (0.3 or 0.5 mg; n = 51 each) or sham ( n = 49). The treatment schedule comprised three monthly injections, after which treatment could be stopped/reinitiated with an opportunity for rescue laser photocoagulation (protocol-defined criteria). After month 1, dose-doubling was permitted (protocol-defined criteria, injection volume increased from 0.05 to 0.1 ml and remained at 0.1 ml thereafter). Efficacy (BCVA and CRT) and safety were compared between pooled ranibizumab and sham arms using the full analysis set ( n = 151, patients receiving ≥1 injection). RESULTS At month 12, mean ± SD BCVA improved from baseline by 10.3 ± 9.1 letters with ranibizumab and declined by 1.4 ± 14.2 letters with sham ( P P P CONCLUSIONS Ranibizumab is effective in improving BCVA and is well tolerated in DME. Future clinical trials are required to confirm its long-term efficacy and safety.
673 citations
••
TL;DR: In this paper, the authors reported the first experimental observation of temporal cavity solitons, which are packets of light persisting in a continuously driven nonlinear resonator and are used to demonstrate storage of a data stream for more than a second.
Abstract: Temporal cavity solitons are packets of light persisting in a continuously driven nonlinear resonator. They are robust attracting states, readily excited through a phase-insensitive and wavelength-insensitive process. As such, they constitute an ideal support for bits in an optical buffer that would seamlessly combine three critical telecommunication functions, namely all-optical storage, all-optical reshaping and wavelength conversion. Here, with standard silica optical fibres, we report the first experimental observation of temporal cavity solitons. The cavity solitons are 4 ps long and are used to demonstrate storage of a data stream for more than a second. We also observe interactions of close cavity solitons, revealing for our set-up a potential capacity of up to 45,000 bits at 25 Gbit s−1. More fundamentally, cavity solitons are localized dissipative structures. Therefore, given that silica exhibits a pure instantaneous Kerr nonlinearity, our experiment constitutes one of the simplest examples of self-organization phenomena in nonlinear optics. Using standard silica optical fibres, scientists observe temporal cavity solitons — packets of light persisting in a continuously driven nonlinear resonator. Cavity solitons 4 ps long are reported and used to demonstrate storage of a data stream for more than a second. The findings represent one of the simplest examples of self-organization phenomena in nonlinear optics.
673 citations
Authors
Showing all 28484 results
Name | H-index | Papers | Citations |
---|---|---|---|
Walter C. Willett | 334 | 2399 | 413322 |
Meir J. Stampfer | 277 | 1414 | 283776 |
Frank E. Speizer | 193 | 636 | 135891 |
Bernard Rosner | 190 | 1162 | 147661 |
Eric Boerwinkle | 183 | 1321 | 170971 |
Rory Collins | 162 | 489 | 193407 |
Monique M.B. Breteler | 159 | 546 | 93762 |
Charles H. Hennekens | 150 | 424 | 117806 |
Rajesh Kumar | 149 | 4439 | 140830 |
Hugh A. Sampson | 147 | 816 | 76492 |
David P. Strachan | 143 | 472 | 105256 |
Jun Lu | 135 | 1526 | 99767 |
Peter Zoller | 134 | 734 | 76093 |
David H. Barlow | 133 | 786 | 72730 |
Henry T. Lynch | 133 | 925 | 86270 |